Skip to main content

Table 2 The attributable fraction of increased T3

From: Comparison of methods for calculating the health costs of endocrine disrupters: a case study on triclosan

Percentiles P0–9 P10–24 P25–49 P50–74 P75–89 P90+
Concentration of TCS (ng/mL) 0 0.3 0.54 1.30 4.91 63.65
Share of population that shows the effect (increased T3) Boys 0 0 0 0 0.000217 0,015093
  Girls 0 0 0 0 0.000102 0.026084
Total number of cases 88,957
Sensitivity analysis
Total number of cases 303,759